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Abstract
Background: Methylmalonic acidemia (MMA) is a metabolic disorder of organic acids and is characterized by the
accumulation of methylmalonic acids.
Case presentation: The patient was a 19-year-old female diagnosed with severe MMA at 3 days of age, who was
scheduled for renal replacement therapy. Preoperatively, there was no evidence of metabolic acidosis or electrolyte
abnormalities. Glucose was administered preoperatively following a 6-h fast. Anesthesia was administered using
thiamylal, remifentanil, rocuronium, and sevoflurane. After tracheal intubation, the patient underwent an ultrasound-
guided bilateral rectus sheath block with ropivacaine. A drop in blood sugar level was treated with 5% glucose.
Extubation was performed after intravenous administration of sugammadex.
Conclusions: We report the anesthetic management of a patient with MMA using a combination of general
anesthesia and rectus sheath block.
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Background
Methylmalonic acidemia (MMA) is a metabolic disorder
of organic acids in which methylmalonic acids accumu-
late due to inactivation of methylmalonyl coenzyme A
mutase (MCM). MMA is characterized by metabolic
acidosis and hyperammonemia and can lead to compli-
cations, including mental retardation, seizures, and renal
failure. In the present study, we report MMA in a patient
undergoing continuous ambulatory peritoneal dialysis
catheter placement under the combination of general
anesthesia and rectus sheath block.
Case presentation
The patient was a 19-year-old female with a height of
163.5 cm and a weight of 21.5 kg. She was born after
38 weeks of gestation and weighed 2624 g without as-
phyxia, but was diagnosed as having severe MMA at
3 days of age due to deterioration of general status, and
the presence of metabolic acidosis and hyperammone-
mia. Complicating her cerebral palsy, she was repeatedly
hospitalized due to acidosis and seizures. Since 2009, her
renal function gradually worsened, and in 2017, plasma
creatinine (Cr) was found to be above 4.0 mg/dl. In
2018, the patient was admitted to the emergency room
due to a deterioration of general status from infection,
and an operation for a continuous ambulatory peritoneal
dialysis catheter placement was scheduled.
Preoperative venous blood gas analysis did not indicate
metabolic acidosis: pH, 7.432; PCO2, 42.1 mmHg; PO2,
38.2 mmHg; and base excess (BE), 2.9 mEq/l. Blood re-
sults showed anemia and renal failure: hemoglobin (Hb),
6.1 g/dl; blood urea nitrogen (BUN), 56.0 mg/dl; Cr,
4.04 mg/dl; and estimated glomerular filtration rate
(eGFR), 13 ml/min/L.
General anesthesia was combined with a peripheral
nerve block. No premedication was administered. After
the patient entered the operating room, electrocardiog-
raphy, saturation of percutaneous oxygen, and noninvasive
arterial pressure were monitored. Anesthesia was induced
using thiamylal (4.6 mg/kg), remifentanil (0.4 mcg/kg/min),
and rocuronium (0.9 mg/kg). After tracheal intubation, the
patient underwent an ultrasound-guided bilateral rectus
sheath block with 0.2% ropivacaine (30 ml). Anesthesia was
maintained with a gas mixture of oxygen and air (FiO2 0.4),
1.0 minimum alveolar anesthetic concentration sevoflurane
(1.2–2%), and remifentanil (0.2–0.4 mcg/kg/min).* Correspondence: tsutsumi@tokushima-u.ac.jp
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Intraoperative arterial blood gas values were as fol-
lows: pH, 7.369; pCO2, 32.9 mmHg; pO2, 182 mmHg;
BE, − 5.9 mEq/l; Na, 140 mmol/l; K, 3.8 mmol/l; and
Cl, 104 mmol/l. Glucose preparation was used to pre-
vent hypoglycemia while maintaining a concentration
of 100–200 mg/dl to ensure optimal dosing. The pre-
operative blood sugar level was 113 mg/dl. Hypotonic
fluid (2.5% glucose) was used in the perioperative
period. Blood sugar level declined to 82 mg/dl during
surgery, and 5% glucose was administered. The level
was 120 mg/dl at the end of the surgery. To avoid peri-
operative accumulation of methylmalonic acid, the
temperature was maintained above 36.0 °C with a heating
device, and clindamycin was administered intravenously.
Throughout the surgery, hemodynamic parameters were
stable, and the operation was over without using vasopres-
sor agents. Extubation was performed after intravenous
administration of sugammadex (4 mg/kg). The duration of
surgery was 2 h and 10 min, and that of anesthesia was
3 h and 30 min. Postoperatively, the patient did not ex-
perience pain at rest; however, she experienced mild pain
during movement. The patient did not use any rescue an-
algesic agents in the postoperative period. Additionally, no
evidence of metabolic acidosis or hyperammonemia
(NH3, 29 μg/dl) was observed. Continuous ambulatory
peritoneal dialysis was started 10 days after the surgery,
and the patient was discharged after 36 days.
Discussion
MMA is an autosomal inherited disease with various
symptoms and ensuing metabolic acidosis, which is
characterized by the accumulation of methylmalonic
acids due to inactivation of the MCM. MCM is present
in the metabolic pathway of four types of amino acids
(valine, isoleucine, methionine, and threonine), choles-
terol, and odd chain fatty acids (OCFAs). Viability of
patients with MMA improves with the progression of
treatment, and MMA is capable of being diagnosed
early by newborn mass screening. The frequency is 1 in
80,000 [1].
In patients with MMA, anesthetic management is im-
portant to prevent acute metabolic failure. Since
hypoglycemia worsens metabolic acidosis by protein ca-
tabolism sthenia, glucose loading should be avoided. Pre-
operative fasting should be as short as possible; some
studies have reported 6 h as an optimal fasting time [2].
If necessary, glucose may be administered during pre-
operative fasting. On the other hand, surgical stress can
also cause protein catabolism sthenia; therefore, depth of
anesthesia should be maintained. Metabolic acidosis
should be actively corrected with sodium bicarbonate
in cases where the condition did not exist preopera-
tively. Since some studies have reported metabolic acid-
osis or ventricular tachycardia with hypokalemia during
anesthetic management in patients with MMA [3], ar-
terial blood gas analysis was performed in the present
study. Although acidemia was observed, the values did
not indicate metabolic acidosis or electrolyte abnormal-
ities. We also administered glucose during surgery due
to decreased blood sugar levels.
Selecting appropriate anesthetic drugs is also import-
ant. Nitrous oxide should not be used because it inter-
feres with adenosylcobalamin [4]. In general, propofol
should also not be administered to patients with MMA.
One study reported that propofol use was associated
with deterioration of metabolic failure during general
anesthesia in a living liver transplantation [2]. Another
study has suggested that propofol may be safe for con-
tinuous intravenous administration, which was used for
sedation during procedures such as magnetic resonance
imaging [5]. A general preparation of propofol consists
of 1% propofol, 10% soybean oil, 2.25% glycerol, and
1.2% purified egg lecithin [6]. Naturally occurring soy-
bean oil and egg lecithin predominantly consist of 16-
and 18-carbon chain fatty acids with minimal-to-none
amounts of OCFAs [7]. Based on this viewpoint, the use
of propofol appears to be safe in patients with MMA.
However, we consider this controversial due to the pos-
sibility of the existence of mild subclinical metabolic
acidosis alleviated by glucose administration. Further-
more, as our patient had complications associated with
end-stage renal failure, we used thiamylal and sevoflur-
ane instead of propofol. Aryl propionic acid, nonsteroi-
dal anti-inflammatory drugs (NSIADs), derivatives of
ibuprofen, loxoprofen, and flurbiprofen axetil were
avoided because they metabolize into methylmalonic
acid. A rectus sheath block was performed with ropiva-
caine to provide postoperative analgesia for midline inci-
sions. Sugammadex was used to reverse the effects of
neuromuscular blocking agents and was shown to be ef-
ficacious and safe.
Anesthetic management of patients with MMA needs
to be tailored based on an assessment of the patho-
physiological condition. Herein, we reported a case of
successful anesthetic management of a patient with
MMA undergoing continuous ambulatory peritoneal dia-
lysis catheter placement using a combination of general
anesthesia and rectus sheath block.
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